<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445334657</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317142750.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20111101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1245/s10434-011-1750-z</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1245/s10434-011-1750-z</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Inguinopelvic Lymphadenectomy Following Positive Inguinal Sentinel Lymph Node Biopsy in Melanoma: True Frequency of Synchronous Pelvic Metastases</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Carrie Chu, Keith Delman, Grant Carlson, Andrea Hestley, Douglas Murray]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Background: True frequency of synchronous pelvic metastases with positive inguinal sentinel lymph node (SLN) biopsy is unknown. Role of pelvic dissection in the SLN era is unclear. Methods: From 1994 to 2004, 1 surgeon routinely performed nonselective, complete inguinopelvic lymphadenectomy after positive inguinal SLN biopsy. All cases were identified from a prospectively maintained database. Clinicopathologic features associated with pelvic disease were assessed. Results: A total of 40 patients with positive inguinal SLN underwent, without additional selection, 42 complete inguinopelvic lymphadenectomies. Median age was 46.5years (range 25-79years); 79% had lower extremity primaries. Median Breslow depth was 2.3mm (range 1.0-10.0mm), Clark's IV/V 98%, ulceration 26%. Frequency of synchronous pelvic disease upon completion lymphadenectomy was 5 of 42 (11.9%). Patients with and without pelvic disease were similar in age, sex, Breslow depth, Clark's level, ulceration, and mitoses. All 5 cases with pelvic metastases had extremity primaries (4 distal, 1 proximal). Of the 5, 3 (60%) had ≥3 total involved inguinal nodes, compared with only 1 (2.7%) of the 37 cases without pelvic disease (P=.003). Ratio of positive to total number inguinal nodes retrieved was &gt;0.20 in 80% of cases with pelvic disease and 8.6% of cases without (P=.002). Upon lymphoscintigraphy review, secondary pelvic drainage was present in 80% of cases with pelvic disease compared with 56% of cases without pelvic disease, though the trend was statistically insignificant (P=.63). Conclusions: In this cohort of unselected, SLN-positive patients with complete inguinopelvic lymphadenectomy, frequency of synchronous pelvic disease was 11.9%. Patients with ≥3 total involved inguinal nodes or inguinal node ratio &gt;0.20 appear more likely to harbor pelvic disease.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Society of Surgical Oncology, 2011</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Chu</subfield>
   <subfield code="D">Carrie</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Delman</subfield>
   <subfield code="D">Keith</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Carlson</subfield>
   <subfield code="D">Grant</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Hestley</subfield>
   <subfield code="D">Andrea</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Murray</subfield>
   <subfield code="D">Douglas</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Annals of Surgical Oncology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">18/12(2011-11-01), 3309-3315</subfield>
   <subfield code="x">1068-9265</subfield>
   <subfield code="q">18:12&lt;3309</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">10434</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1245/s10434-011-1750-z</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1245/s10434-011-1750-z</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Chu</subfield>
   <subfield code="D">Carrie</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Delman</subfield>
   <subfield code="D">Keith</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Carlson</subfield>
   <subfield code="D">Grant</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Hestley</subfield>
   <subfield code="D">Andrea</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Murray</subfield>
   <subfield code="D">Douglas</subfield>
   <subfield code="u">Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine &amp; The Winship Cancer Institute, Atlanta, GA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Annals of Surgical Oncology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">18/12(2011-11-01), 3309-3315</subfield>
   <subfield code="x">1068-9265</subfield>
   <subfield code="q">18:12&lt;3309</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">10434</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
